Increased expression of lipocalin-type-prostaglandin D synthase in ulcerative colitis and exacerbating role in murine colitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 300, Issue 3, 2011, Pages 401-408

  Hokari, Ryota ^a   Kurihara, Chie ^a   Nagata, Nanae ^b   Aritake, Kosuke ^b   Okada, Yoshikiyo ^a   Watanabe, Chikako ^a   Komoto, Shunsuke ^a   Nakamura, Mitsuyasu ^a   Kawaguchi, Atsushi ^a   Nagao, Shigeaki ^a   Urade, Yoshihiro ^b   Miura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Chemoattractant receptorhomologous molecule expressed on Th2 cells; Dextran sodium sulfate; Prostaglandin D2; Ulcerative colitis

Indexed keywords

CYCLOOXYGENASE 2; DEXTRAN SULFATE; DRINKING WATER; LIPOCALIN; MERCAPTOPURINE; MESALAZINE; MESSENGER RNA; PREDNISOLONE; PROSTAGLANDIN D SYNTHASE; SALAZOSULFAPYRIDINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; COLITIS; COLON BIOPSY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH MUSCLE; TISSUE SECTION; ULCERATIVE COLITIS;

ADULT; ANIMALS; BIOPSY; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; COLONOSCOPY; CYCLOOXYGENASE 2; DEXTRAN SULFATE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINAL MUCOSA; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PEROXIDASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; UP-REGULATION; YOUNG ADULT;

EID: 79954552439     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00351.2010     Document Type: Article

References (33)

1. Ajuebor MN, Singh A, Wallace JL. Cyclooxygenase-2-derived prostaglandin D2 is an early anti-inflammatory signal in experimental colitis. Am J Physiol Gastrointest Liver Physiol 279: G238-G244, 2000.
2. Alving K, Matran R, Lundberg JM. The possible role of prostaglandin D2 in the long-lasting airways vasodilatation induced by allergen in the sensitized pig. Acta Physiol Scand 143: 93-103, 1991.
3. Azuma Y, Watanabe K, Date M, Daito M, Ohura K. Possible involvement of p38 in mechanisms underlying acceleration of proliferation by 15-deoxy-Delta(12,14)-prostaglandin J2 and the precursors in leukemia cell line THP-1. J Pharmacol Sci 94: 261-270, 2004.
4. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role of prostaglandins in gastroprotection and gastric adaptation. J Physiol Pharmacol 56, Suppl 5: 33-55, 2005.
5. Christ-Hazelhof E, Nugteren DH. Purification and characterisation of prostaglandin endoperoxide D-isomerase, a cytoplasmic, glutathione-requiring enzyme. Biochim Biophys Acta 572: 43-51, 1979.
6. Cipollone F, Fazia M, Iezzi A, Ciabattoni G, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, De Luca M, Prontera C, Chiarelli F, Cuccurullo F, Mezzetti A. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol 24: 1259-1265, 2004.
7. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238-249, 1993.
8. Eguchi Y, Eguchi N, Oda H, Seiki K, Kijima Y, Matsu-ura Y, Urade Y, Hayaishi O. Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci USA 94: 14689-14694, 1997.
9. Eguchi N, Minami T, Shirafuji N, Kanaoka Y, Tanaka T, Nagata A, Yoshida N, Urade Y, Ito, Hayaishi SO. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci USA 96: 726-730, 1999.
10. Evans JM, McMahon AD, Murray FE, McDevitt DG, MacDonald TM. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 40: 619-622, 1997.
11. Felder JB, Korelitz BI, Rajapakse R, Schwarz S, Horatagis AP, Gleim G. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol 95: 1949-1954, 2000.
12. Heavey DJ, Ernst PB, Stevens RL, Befus AD, Bienenstock J, Austen KF. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells. J Immunol 140: 1953-1957, 1988.
13. Honda K, Arima M, Cheng G, Taki S, Hirata H, Eda F, Fukushima F, Yamaguchi B, Hatano M, Tokuhisa T, Fukuda T. Prostaglandin D2 reinforces Th2 type inflammatory responses of airways to low-dose antigen through bronchial expression of macrophage-derived chemokine. J Exp Med 198: 533-543, 2003.
14. Joo M, Kwon M, Sadikot RT, Kingsley PJ, Marnett LJ, Blackwell TS, Peebles RS Jr, Urade Y, Christman JW. Induction and function of lipocalin prostaglandin D synthase in host immunity. J Immunol 179: 2565-2575, 2007.
15. Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, Tsuboi K, Sugimoto Y, Kobayashi T, Miyachi Y, Ichikawa A, Narumiya S. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 109: 883-893, 2002.
16. Kabashima K, Narumiya S. The DP receptor, allergic inflammation and asthma. Prostaglandins Leukot Essent Fatty Acids 69: 187-194, 2003.
17. Matsumoto H, Naraba H, Murakami M, Kudo I, Yamaki K, Ueno A, Oh-ishi S. Biochem Biophys Res Commun. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. 230: 110-114, 1997.
18. Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, Eguchi N, Urade Y, Yoshida N, Kimura K, Mizoguchi A, Honda Y, Nagai H, Narumiya S. Prostaglandin D2 as a mediator of allergic asthma. Science 287: 2013-1037, 2000.
19. Matsuzaki K, Hokari R, Kato S, Tsuzuki Y, Tanaka H, Kurihara C, Iwai A, Kawaguchi A, Nagao S, Itoh K, Nagata K, Miura S. Differential expression of CCR5 and CRTH2 on infiltrated cells in colonic mucosa of patients with ulcerative colitis. J Gastroenterol Hepatol 18: 1081-1088, 2003.
20. Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 30: 393-410, 1961.
21. -/- mice. Free Radic Biol Med 34: 1153-1166, 2003.
22. Nieto N, Fernandez MI, Torres MI, Ríos A, Suarez MD, Gil A. Dietary monounsaturated n-3 and n-6 long-chain polyunsaturated fatty acids affect cellular antioxidant defense system in rats with experimental ulcerative colitis induced by trinitrobenzene sulfonic acid. Dig Dis Sci 43: 2676-2687, 1998.
23. Ragolia L, Palaia T, Paric E, Maesaka JK. Prostaglandin D2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cells. J Biol Chem 278: 22175-22181, 2003.
24. Ragolia L, Palaia T, Paric E, Maesaka JK. Elevated L-PGDS activity contributes to PMA-induced apoptosis concomitant with downregulation of PI3-K. Am J Physiol Cell Physiol 284: C119-C126, 2003.
25. Sasaki S, Hirata I, Maemura K, Hamamoto N, Murano M, Toshina K, Katsu K. Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the levels of mucosal inflammatory cytokines. Scand J Immunol 51: 23-28, 2000.
26. Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, Tuma R, Ganea D. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23->IL-17 axis. J Immunol 178: 8138-8147, 2007.
27. Shiraishi Y, Asano K, Nakajima T, Oguma T, Suzuki Y, Shiomi T, Sayama K, Niimi K, Wakaki M, Kagyo J, Ikeda E, Hirai H, Yamaguchi K, Ishizaka A. Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. J Pharmacol Exp Ther 312: 954-960, 2005.
28. Shoda R, Matsueda K, Yamato S, Umeda N. Therapeutic efficacy of N-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol 30, Suppl 8: 98-101, 1995.
29. Soter NA, Lewis RA, Corey EJ, Austen KF. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol 80: 115-119, 1983.
30. Urade Y, Fujimoto N, Hayaishi O. Purification and characterization of rat brain prostaglandin D synthetase. J Biol Chem 260: 12410-12415, 1985.
31. Urade Y, Eguchi N. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat 68-69: 375-382, 2002.
32. Urade Y, Fujimoto N, Ujihara M, Hayaishi O. Biochemical and immunological characterization of rat spleen prostaglandin D synthetase. J Biol Chem 262: 3820-3825, 1987.
33. Yun JC, Ohman KP, Gill JR Jr, Keiser H. Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619). Can J Physiol Pharmacol 69: 599-604, 1991.